Trexquant Investment LP Ngm Biopharmaceuticals Inc Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $443,734 - $622,779	35,245 New	35,245 $461,000
Q2 2022 Aug 11, 2022	SELL	$10.58 - $17.5 $266,055 - $440,072	-25,147 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.81 - $18.6 $91,670 - $123,466	6,638 Added 35.86%	25,147 $383,000
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $148,815 - $189,856	-8,622 Reduced 31.78%	18,509 $328,000
Q3 2021 Nov 12, 2021	BUY	$20.15 - $26.19 $546,689 - $710,560	27,131 New	27,131 $570,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.